This content is from: Premium
Icahn Inspires Another Poison Pill
Hologic made the move after the legendary investor took a big stake. Is the pill just what the doctor ordered, or will it be bad medicine for investors?
When Carl Icahn late Wednesday disclosed a 12.63 percent stake in Hologic, the maker of medical devices geared toward women did what many companies do these days: It rushed out a poison pill designed to thwart activists from gaining control of a big chunk of its stock. Sometimes called special-purpose shareholder
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.